Strata Critical Medical, Inc.

NASDAQ:SRTA

Airlines, Airports & Air Services

Industrials
$4.96 -0.43%

-$0.03 today

Market cap
$443.03M
Beta
2.20
P/E (TTM)
9.7
EPS (TTM)
$0.60
52W Low $3.57High $6.50

Volume 0.99M

Average 0.91M

SRTA Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Strata Critical Medical, Inc.NASDAQ: SRTA

Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026

Capital expenditures growth accelerates

Q1 FY2026 capital expenditures of $5.48M (cash outflow) rose 73.9% year over year, ahead of the -62.4% change in trailing-twelve-month capital expenditures. Sequentially, it rose 196.6% from the prior quarter. Over 3 fiscal years it compounded at +147.1% a year.

Context

  • Capital expenditures amounted to 5.6% of revenue in FY2025, down 7.7 pp from a year earlier.
  • Capital expenditures grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +73.9% holds above the trailing-twelve-month pace of -62.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$5.48M+196.6% QoQ
Last fiscal yearDec 2025
-$11.01M-66.6% YoY
LTMMar 2026
-$13.18M-62.4% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+73.9%——
1 year-66.6%——
3-year CAGR+147.1%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(11.01M) USD
Year-over-year change
+66.6%

Capital Expenditures vs competitors

How SRTA compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -62.4% is the 8th highest of 9, against a peer median of +34.8%.
  • Capital expenditures amounts to 5.2% of revenue for SRTA, versus a peer median of 4.4%.
SRTA Competitors
Capital Expenditures for SRTA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ULHUniversal Logistics Holdings, Inc.LTM Apr 2026$181.17M USD-23.1%+24.2%11.7%
FLYXflyExclusive, Inc.LTM Mar 2026$56.89M USD+29.1%-40.4%14.8%
ORNOrion Group Holdings, Inc.LTM Mar 2026$38.4M USD+80.5%+38.6%4.4%
CYRXCryoport, Inc.LTM Mar 2026$23.86M USD+40.5%-6.9%13.0%
KFRCKforce Inc.LTM Mar 2026$14.04M USD+42.5%+22.3%1.1%
SRTAStrata Critical Medical, Inc.LTM Mar 2026$13.18M USD-62.4%+147.1%5.2%
EBFEnnis, Inc.LTM Feb 2026$11.71M USD+98.8%+130.0%3.0%
MTRXMatrix Service CompanyLTM Mar 2026$6.36M USD-5.4%+32.0%0.8%
AIROAIRO Group Holdings, Inc. Common StockLTM Mar 2026$4.8M USD—+239.1%5.5%
ZIPZipRecruiter, Inc.LTM Mar 2026$1.96M USD-79.3%-53.2%0.4%
EVTLVertical Aerospace Ltd.LTM Mar 2026£555.43K GBP—-47.9%—
Peer median (excluding SRTA) —+34.8%+23.2%4.4%

Competitors are the stored peer set for SRTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Sep 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(40.05M)(27.26M)(56.08M)(27.31M)41.35M
Depreciation & Amortization596K5.73M7.11M5.96M8.19M
Deferred Income Tax(3.64M)(772K)(1.47M)(255K)432K
Stock-Based Compensation9.62M8.28M12.5M19.89M17.83M
Change in Working Capital(2.2M)(17K)(6.74M)(3.01M)(9.08M)
Accounts Receivables(414K)(5.35M)(10.25M)(998K)(12.03M)
Inventory00000
Accounts Payables09.9M000
Other Working Capital(1.79M)(4.57M)3.52M(2.01M)2.95M
Other Non-Cash Items20.06M(23.08M)12.32M2.2M(107.63M)
Operating Cash Flow(15.62M)(37.13M)(32.35M)(2.52M)(48.91M)
Capital Expenditures(801K)(730K)(2.11M)(32.99M)(11.01M)
Acquisitions (Net)(23.07M)(48.1M)(39K)(2.23M)(69.35M)
Purchases of Investments(308.77M)(228.21M)(265.97M)(143.26M)(146.26M)
Sales of Investments11.3M356.38M285.07M177.45M296.36M
Other Investing Activities(504K)0138K(2.11M)(1.42M)
Investing Cash Flow(321.34M)79.34M17.09M(1.02M)69.75M
Debt Repayment(1.17M)0000
Common Stock Issued119.63M87K00193K
Common Stock Repurchased000(244K)0
Dividends Paid00000
Other Financing Activities213.79M(1.17M)(76K)(5.52M)(9.11M)
Financing Cash Flow332.26M(1.08M)(76K)(5.76M)(8.91M)
Effect of Forex Changes10.97M(4.29M)(66K)(80K)(339K)
Net Change in Cash(4.69M)36.84M(15.4M)(9.37M)11.59M
Free Cash Flow(16.42M)(37.86M)(34.46M)(35.51M)(59.92M)

Strata Critical Medical, Inc.

NASDAQ:SRTA

Intrinsic Alpha fair value

Locked

Current Price

$4.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.